• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR TREK CORONARY DILATATION CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR TREK CORONARY DILATATION CATHETER Back to Search Results
Catalog Number 1012274-12
Medical Device Problem Code Material Separation (1562)
Health Effect - Clinical Codes Low Blood Pressure/ Hypotension (1914); Myocardial Infarction (1969); Cardiogenic Shock (2262); Obstruction/Occlusion (2422)
Date of Event 08/28/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
 
Event or Problem Description
It was reported that the procedure was performed to treat a lesion in the circumflex (cx) coronary artery with no calcification and no tortuosity.The procedure was completed with a 3.0x12mm trek balloon dilatation catheter (bdc); however, during removal the balloon became separated in two pieces inside the patient's body; therefore, a stent was used to trap the balloon portion.It was noted that the patient became hypotensive, developed a st elevated myocardial infarction and cardiogenic shock; therefore, a a heart pump was used and the patient was hospitalized for 7 days.There was a delay in the procedure and the patient was hospitalized.No additional information was provided.
 
Additional Manufacturer Narrative
Visual inspection was performed on the returned device.The reported separation was confirmed.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents/complaints from this lot.The investigation was unable to determine a conclusive cause for the reported separation; however, the reported delay to treatment/therapy, hospitalization and unexpected medical intervention appear to be related to circumstances of the procedure.The reported patient effects of hypotension, myocardial infraction and obstruction/occlusion are listed in the coronary dilatation catheters (cdc), trek rx, instructions for use as known patient effects.A conclusive cause for the reported patient effects, and the relationship to the device, if any, cannot be determined.There is no indication of a product quality issue with respects to the design, manufacture, or labeling of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TREK CORONARY DILATATION CATHETER
Common Device Name
CORONARY DILATATION CATHETER
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR COSTA RICA, REG # 3009564766
52 calle 3 b31 coyol free zone
el coyol alajuela
CS  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key18102979
Report Number2024168-2023-12470
Device Sequence Number15361987
Product Code LOX
UDI-Device Identifier08717648138423
UDI-Public08717648138423
Combination Product (Y/N)N
Initial Reporter StateMT
Initial Reporter CountryUS
PMA/510(K) Number
K103110
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/26/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/31/2026
Device Catalogue Number1012274-12
Device Lot Number30417G1
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/31/2023
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 10/16/2023
Supplement Date Received by Manufacturer12/19/2023
Initial Report FDA Received Date11/09/2023
Supplement Report FDA Received Date12/26/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured04/17/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention; Hospitalization;
Patient SexUnknown
-
-